Connection

Search Results to Rhoda Alani, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Alani, Rhoda

PropertyValue
Research Expertise & Professional Interests Rhoda M. Alani, MD is the Herbert Mescon Professor and Chair of Dermatology at Boston University School of Medicine and Boston Medical Center. She received her MD degree with Honors and Distinction in Research from the University of Michigan and completed her internship in internal medicine at Yale-New Haven Hospital and a residency in dermatology at Harvard Medical School. From 1999-2009 Dr. Alani was the Director of the Laboratory of Cutaneous Oncology and Director of the Melanoma and Pigmented Lesion Clinics in Dermatology at Johns Hopkins. Dr. Alani’s research focus is in understanding the molecular basis of melanoma development and progression with the aim of translating her laboratory findings to better prevention, detection, diagnosis, and treatment of melanoma. Dr. Alani is a member of Phi Beta Kappa and Alpha Omega Alpha Honor Societies, the American Academy of Dermatology, the Society for Investigative Dermatology, the American Association for Cancer Research and was elected to the American Society for Clinical Investigation in 2005. She is the author of numerous scientific publications and is the owner of several US patents related to melanoma biomarkers, novel melanoma therapies, and imaging systems for improved melanoma detection
Self-Described Keywords Cancer biology
Self-Described Keywords Skin cancers and prevention
Self-Described Keywords Melanoma biology
Self-Described Keywords Epigenetic therapies for cancer

One or more keywords matched the following items that are connected to Alani, Rhoda

Item TypeName
Concept Lung Neoplasms
Concept Molecular Biology
Concept Neoplasms
Concept Neoplasms, Experimental
Concept Skin Neoplasms
Concept Neoplasms, Second Primary
Concept Brain Stem Neoplasms
Academic Article Human papillomaviruses and associated malignancies.
Academic Article The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Academic Article Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.
Academic Article Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1.
Academic Article Id proteins in cell growth and tumorigenesis.
Academic Article Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.
Academic Article Tumor angiogenesis in mice and men.
Academic Article Toward a molecular classification of melanoma.
Academic Article BRAF kinase in melanoma development and progression.
Academic Article Id1 expression is transcriptionally regulated in radial growth phase melanomas.
Academic Article Nonmelanoma skin cancer and risk for subsequent malignancy.
Academic Article Melanoma biomarkers: current status and vision for the future.
Academic Article The association between skin characteristics and skin cancer prevention behaviors.
Academic Article Cigarette smoking and malignant melanoma: a case-control study.
Academic Article Id1 promotes tumor cell migration in nonsmall cell lung cancers.
Academic Article Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.
Academic Article Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
Academic Article Sun-seeking behavior to increase cutaneous vitamin D synthesis: when prevention messages conflict.
Academic Article Neuropilin-2: a novel biomarker for malignant melanoma?
Academic Article A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer.
Academic Article A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.
Academic Article A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.
Academic Article DNA repair gene variants in relation to overall cancer risk: a population-based study.
Academic Article MicroRNAs as an emerging target for melanoma therapy.
Academic Article Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells.
Academic Article Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma.
Academic Article Early events in the neoplastic transformation of respiratory epithelium.
Academic Article Detection of circulating tumor DNA in early- and late-stage human malignancies.
Academic Article Neuropilin-2 promotes melanoma growth and progression in vivo.
Academic Article Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.
Academic Article Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
Academic Article Emerging Biomarkers in Cutaneous Melanoma.
Award or Honor Receipt Inaugural Graduate Student Professor of the Year Lecturer
Award or Honor Receipt Stewart Scholar Award in Cancer Research
Award or Honor Receipt Stewart Scholar Award in Cancer Research
Academic Article USE OF HISTONE ACETYLTRANSFERASE INHIBITORS AS NOVEL ANTI-CANCER THERAPIES
Academic Article American Society of Biochemistry and Molecular Biology Annual Meeting
Academic Article Epigenetics in Cancer Therapy
Academic Article Johns Hopkins Biotech 2007: Investing in Cancer Research
Academic Article Proc Annu Meet Am Assoc Cancer Res
Academic Article MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.
Academic Article Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
Grant Center for Innovation in Point of Care Technologies for the Future of Cancer Care

Highlights
Search Criteria
  • cancer
  • biology